Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

The impact of short-term professional continuous glucose monitoring on glycemic control via lifestyle Improvement

Tools
- Tools
+ Tools

Shibusawa, Ryo, Yamada, Eijiro, Okada, Shuichi, Nakajima, Y., Bastie, Claire C. and Yamada, Masanobu (2018) The impact of short-term professional continuous glucose monitoring on glycemic control via lifestyle Improvement. Diabetes Technology & Therapeutics, 9 . pp. 628-631. doi:10.1089/dia.2018.0164

Research output not available from this repository, contact author.
Official URL: https://doi.org/10.1089/dia.2018.0164

Request Changes to record.

Abstract

Background: The efficacy of short-term professional continuous glucose monitoring (CGM) for glycemic control in patients with diabetes remains unclear.

Methods: We performed a 3-month study to evaluate the benefits of CGM in 64 patients.

Results: The overall glycemic control of patients who underwent CGM improved significantly; however, that of patients maintaining the same medications did not improve overall. Thirty-one patients with unchanged medications were divided into improved (n = 12) versus nonimproved (n = 19) groups. In the improved group, baseline hemoglobin A1c (HbA1c) levels were higher than in the nonimproved group (P = 0.0066) despite mean blood glucose levels remaining the same (P = 0.3406). The improved group also exhibited lower glucose variability.

Conclusions: Patients with lower than expected mean glucose levels, based on HbA1c values, and patients with lower glucose level variability during CGM may be able to improve their glycemic control after lifestyle change without treatment modification.

Item Type: Journal Article
Subjects: Q Science > Q Science (General)
Divisions: Faculty of Medicine > Warwick Medical School > Biomedical Sciences
Faculty of Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine
Faculty of Medicine > Warwick Medical School
Journal or Publication Title: Diabetes Technology & Therapeutics
Publisher: Mary Ann Liebert, Inc. Publishers
ISSN: 1520-9156
Official Date: 1 September 2018
Dates:
DateEvent
1 September 2018Published
20 September 2018Available
12 August 2018Accepted
Volume: 9
Page Range: pp. 628-631
DOI: 10.1089/dia.2018.0164
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us